Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning. Today we take a look
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we
Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week
Awakn Life Sciences (NEO: AWKN, OTCQB: AWKNF), a clinical-stage biotechnology company specializing in the development of ketamine-assisted treatments for addiction, has entered into a global
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including
More than a year after the federal government first cut off her disability benefits, Denise Woods drives nightly to strip malls, truck stops, and parking
Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen,
Cam Roberson, VP at Beachhead Solutions Healthcare delivery organizations and those working with them that are still in business are either well aware of their
LONDON — The Belgian company Argenx said Wednesday that its closely watched antibody therapy failed to outperform placebo in a Phase 3 trial in an
In this interview, News Medical speaks with Ascential Technologies about the evolution of medical manufacturing trends and how users can stay ahead of the trends